{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:49:26Z","timestamp":1790804966653,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92149303"],"award-info":[{"award-number":["92149303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92049202"],"award-info":[{"award-number":["92049202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071213"],"award-info":[{"award-number":["82071213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021ZD0202402"],"award-info":[{"award-number":["2021ZD0202402"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021YFA1100012"],"award-info":[{"award-number":["2021YFA1100012"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Apolipoprotein E (APOE) plays a pivotal role in lipid including cholesterol metabolism. The APOE <jats:italic>\u03b54<\/jats:italic> (APOE4) allele is a major genetic risk factor for Alzheimer\u2019s and cardiovascular diseases. Although APOE has recently been associated with increased susceptibility to infections of several viruses, whether and how APOE and its isoforms affect SARS-CoV-2 infection remains unclear. Here, we show that serum concentrations of APOE correlate inversely with levels of cytokine\/chemokine in 73 COVID-19 patients. Utilizing multiple protein interaction assays, we demonstrate that APOE3 and APOE4 interact with the SARS-CoV-2 receptor ACE2; and APOE\/ACE2 interactions require zinc metallopeptidase domain of ACE2, a key docking site for SARS-CoV-2 Spike protein. In addition, immuno-imaging assays using confocal, super-resolution, and transmission electron microscopies reveal that both APOE3 and APOE4 reduce ACE2\/Spike-mediated viral entry into cells. Interestingly, while having a comparable binding affinity to ACE2, APOE4 inhibits viral entry to a lesser extent compared to APOE3, which is likely due to APOE4\u2019s more compact structure and smaller spatial obstacle to compete against Spike binding to ACE2. Furthermore, <jats:italic>APOE \u03b54<\/jats:italic> carriers clinically correlate with increased SARS-CoV-2 infection and elevated serum inflammatory factors in 142 COVID-19 patients assessed. Our study suggests a regulatory mechanism underlying SARS-CoV-2 infection through APOE interactions with ACE2, which may explain in part increased COVID-19 infection and disease severity in <jats:italic>APOE \u03b54<\/jats:italic> carriers.<\/jats:p>","DOI":"10.1038\/s41392-022-01118-4","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T06:02:55Z","timestamp":1659333775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients"],"prefix":"10.1038","volume":"7","author":[{"given":"Hongsheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1857-2798","authenticated-orcid":false,"given":"Quan-Xin","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangtong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingchang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-7423","authenticated-orcid":false,"given":"Ai-Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7031-7853","authenticated-orcid":false,"given":"Huaxi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"1118_CR1","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.mayocp.2021.07.005","volume":"96","author":"MS Parmar","year":"2021","unstructured":"Parmar, M. S. TMPRSS2: an equally important protease as ACE2 in the pathogenicity of SARS-CoV-2 infection. Mayo Clin. Proc. 96, 2748\u20132752 (2021).","journal-title":"Mayo Clin. Proc."},{"key":"1118_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01673-z","volume":"18","author":"Y Hou","year":"2020","unstructured":"Hou, Y. et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med. 18, 216 (2020).","journal-title":"BMC Med."},{"key":"1118_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19057-5","volume":"11","author":"J Fajnzylber","year":"2020","unstructured":"Fajnzylber, J. et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 11, 5493 (2020).","journal-title":"Nat. Commun."},{"key":"1118_CR4","doi-asserted-by":"crossref","unstructured":"Kousathanas, A. et al. Whole genome sequencing reveals host factors underlying critical Covid-19. Nature 607, 97\u2013103 (2022).","DOI":"10.1038\/s41586-022-04576-6"},{"key":"1118_CR5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/gerona\/glaa131","volume":"75","author":"CL Kuo","year":"2020","unstructured":"Kuo, C. L. et al. APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort. J. Gerontol. A Biol. Sci. Med. Sci. 75, 2231\u20132232 (2020).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"1118_CR6","doi-asserted-by":"publisher","first-page":"622176","DOI":"10.3389\/fimmu.2021.622176","volume":"12","author":"I Fricke-Galindo","year":"2021","unstructured":"Fricke-Galindo, I. & Falfan-Valencia, R. Genetics insight for COVID-19 susceptibility and severity: a review. Front. Immunol. 12, 622176 (2021).","journal-title":"Front. Immunol."},{"key":"1118_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1046\/j.1469-1809.1999.6340301.x","volume":"63","author":"RM Corbo","year":"1999","unstructured":"Corbo, R. M. & Scacchi, R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a \u2018thrifty\u2019 allele? Ann. Hum. Genet. 63, 301\u2013310 (1999).","journal-title":"Ann. Hum. Genet."},{"key":"1118_CR8","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/alz.12153","volume":"16","author":"L Jia","year":"2020","unstructured":"Jia, L. et al. The APOE epsilon4 exerts differential effects on familial and other subtypes of Alzheimer\u2019s disease. Alzheimers Dement. 16, 1613\u20131623 (2020).","journal-title":"Alzheimers Dement."},{"key":"1118_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.2174\/1567205013666160401115307","volume":"13","author":"L Zheng","year":"2016","unstructured":"Zheng, L. et al. Association of apolipoprotein E (ApoE) polymorphism with Alzheimer\u2019s disease in Chinese population. Curr. Alzheimer Res. 13, 912\u2013917 (2016).","journal-title":"Curr. Alzheimer Res."},{"key":"1118_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/03014460600594513","volume":"33","author":"PP Singh","year":"2006","unstructured":"Singh, P. P., Singh, M. & Mastana, S. S. APOE distribution in world populations with new data from India and the UK. Ann. Hum. Biol. 33, 279\u2013308 (2006).","journal-title":"Ann. Hum. Biol."},{"key":"1118_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","volume":"15","author":"Z Li","year":"2020","unstructured":"Li, Z., Shue, F., Zhao, N., Shinohara, M. & Bu, G. APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease. Mol. Neurodegener. 15, 63 (2020).","journal-title":"Mol. Neurodegener."},{"key":"1118_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"1118_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol. Neurodegener. 15, 40 (2020).","journal-title":"Mol. Neurodegener."},{"key":"1118_CR14","doi-asserted-by":"publisher","first-page":"618651","DOI":"10.3389\/fcvm.2020.618651","volume":"7","author":"JM Condor Capcha","year":"2020","unstructured":"Condor Capcha, J. M. et al. Generation of SARS-CoV-2 spike pseudotyped virus for viral entry and neutralization assays: a 1-week protocol. Front. Cardiovasc. Med 7, 618651 (2020).","journal-title":"Front. Cardiovasc. Med"},{"key":"1118_CR15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016\u20131035 e1019 (2020).","journal-title":"Cell"},{"key":"1118_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","volume":"28","author":"SH Sun","year":"2020","unstructured":"Sun, S. H. et al. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe 28, 124\u2013133 e124 (2020).","journal-title":"Cell Host Microbe"},{"key":"1118_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12929-021-00729-3","volume":"28","author":"SH Tseng","year":"2021","unstructured":"Tseng, S. H. et al. A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventions. J. Biomed. Sci. 28, 34 (2021).","journal-title":"J. Biomed. Sci."},{"key":"1118_CR18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","volume":"583","author":"L Bao","year":"2020","unstructured":"Bao, L. et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature 583, 830\u2013833 (2020).","journal-title":"Nature"},{"key":"1118_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41586-021-03673-2","volume":"595","author":"Z Ku","year":"2021","unstructured":"Ku, Z. et al. Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants. Nature 595, 718\u2013723 (2021).","journal-title":"Nature"},{"key":"1118_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"1118_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apsb.2020.10.006","volume":"11","author":"J Bian","year":"2021","unstructured":"Bian, J. & Li, Z. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharm. Sin. B 11, 1\u201312 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"1118_CR22","doi-asserted-by":"publisher","first-page":"13752","DOI":"10.1039\/D1CP01611C","volume":"23","author":"Y Zang","year":"2021","unstructured":"Zang, Y. et al. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins. Phys. Chem. Chem. Phys. 23, 13752\u201313759 (2021).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"1118_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(20)31757-8","volume":"396","author":"BE Young","year":"2020","unstructured":"Young, B. E. et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet 396, 603\u2013611 (2020).","journal-title":"Lancet"},{"key":"1118_CR24","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.1074\/jbc.M200581200","volume":"277","author":"C Vickers","year":"2002","unstructured":"Vickers, C. et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 277, 14838\u201314843 (2002).","journal-title":"J. Biol. Chem."},{"key":"1118_CR25","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","volume":"50","author":"RW Mahley","year":"2009","unstructured":"Mahley, R. W., Weisgraber, K. H. & Huang, Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS. J. Lipid Res. 50, S183\u2013S188 (2009).","journal-title":"J. Lipid Res."},{"key":"1118_CR26","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/eurheartj\/ehz402","volume":"40","author":"KL Rasmussen","year":"2019","unstructured":"Rasmussen, K. L., Tybjaerg-Hansen, A., Nordestgaard, B. G. & Frikke-Schmidt, R. Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort. Eur. Heart J. 40, 2813\u20132824 (2019).","journal-title":"Eur. Heart J."},{"key":"1118_CR27","doi-asserted-by":"crossref","unstructured":"Douaud, G. et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604, 697\u2013707 (2022).","DOI":"10.1038\/s41586-022-04569-5"},{"key":"1118_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-020-00395-3","volume":"15","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer\u2019s disease. Mol. Neurodegener. 15, 55 (2020).","journal-title":"Mol. Neurodegener."},{"key":"1118_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.stem.2020.12.018","volume":"28","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response. Cell Stem Cell 28, 331\u2013342 e335 (2021).","journal-title":"Cell Stem Cell"},{"key":"1118_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/JAD-200940","volume":"78","author":"JA Matias-Guiu","year":"2020","unstructured":"Matias-Guiu, J. A., Pytel, V. & Matias-Guiu, J. Death rate due to COVID-19 in Alzheimer\u2019s disease and frontotemporal dementia. J. Alzheimers Dis. 78, 537\u2013541 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"1118_CR31","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3233\/JAD-200937","volume":"78","author":"P Martin-Jimenez","year":"2020","unstructured":"Martin-Jimenez, P. et al. Cognitive impairment is a common comorbidity in deceased COVID-19 patients: a Hospital-based Retrospective Cohort Study. J. Alzheimers Dis. 78, 1367\u20131372 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"1118_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13024-021-00469-w","volume":"16","author":"YH Liu","year":"2021","unstructured":"Liu, Y. H. et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol. Neurodegener. 16, 48 (2021).","journal-title":"Mol. Neurodegener."},{"key":"1118_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-021-00492-x","volume":"16","author":"GS Day","year":"2021","unstructured":"Day, G. S. Measuring the cognitive costs of the COVID-19 pandemic. Mol. Neurodegener. 16, 67 (2021).","journal-title":"Mol. Neurodegener."},{"key":"1118_CR34","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1128\/JVI.00006-06","volume":"80","author":"JS Burgos","year":"2006","unstructured":"Burgos, J. S., Ramirez, C., Sastre, I. & Valdivieso, F. Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA. J. Virol. 80, 5383\u20135387 (2006).","journal-title":"J. Virol."},{"key":"1118_CR35","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1073\/pnas.0803526105","volume":"105","author":"TD Burt","year":"2008","unstructured":"Burt, T. D. et al. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4\/epsilon4 genotype accelerates HIV disease progression. Proc. Natl Acad. Sci. USA 105, 8718\u20138723 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1118_CR36","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448 (2020).","journal-title":"Science"},{"key":"1118_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s40478-021-01302-7","volume":"9","author":"SN Kurki","year":"2021","unstructured":"Kurki, S. N. et al. APOE epsilon4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study. Acta Neuropathol. Commun. 9, 199 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"1118_CR38","first-page":"100095","volume":"3","author":"F Thibord","year":"2022","unstructured":"Thibord, F., Chan, M. V., Chen, M. H. & Johnson, A. D. A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors. HGG Adv. 3, 100095 (2022).","journal-title":"HGG Adv."},{"key":"1118_CR39","doi-asserted-by":"crossref","unstructured":"de Rojas, I. et al. Genomic characterization of host factors related to SARS-CoV-2 infection in people with dementia and control populations: the GR@ACE\/DEGESCO study. J. Pers. Med. 11, 1318 (2021).","DOI":"10.3390\/jpm11121318"},{"key":"1118_CR40","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.tem.2020.06.003","volume":"31","author":"RB Oria","year":"2020","unstructured":"Oria, R. B., de Almeida, J. Z., Moreira, C. N., Guerrant, R. L. & Figueiredo, J. R. Apolipoprotein E effects on mammalian ovarian steroidogenesis and human fertility. Trends Endocrinol. Metab. 31, 872\u2013883 (2020).","journal-title":"Trends Endocrinol. Metab."},{"key":"1118_CR41","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1084\/jem.20171413","volume":"214","author":"TY Huang","year":"2017","unstructured":"Huang, T. Y. et al. SORLA attenuates EphA4 signaling and amyloid beta-induced neurodegeneration. J. Exp. Med. 214, 3669\u20133685 (2017).","journal-title":"J. Exp. Med."},{"key":"1118_CR42","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","volume":"26","author":"QX Long","year":"2020","unstructured":"Long, Q. X. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 26, 1200\u20131204 (2020).","journal-title":"Nat. Med."},{"key":"1118_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-016-0069-4","volume":"11","author":"L Zhong","year":"2016","unstructured":"Zhong, L. et al. A rapid and cost-effective method for genotyping apolipoprotein E gene polymorphism. Mol. Neurodegener. 11, 2 (2016).","journal-title":"Mol. Neurodegener."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01118-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01118-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01118-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:07:09Z","timestamp":1669230429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01118-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1038\/s41392-022-01118-4","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.X. is one of the Editorial Board Members of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}